UV-radiation in HIV-infected patients;UV-therapie bei HIV-patienten

Hautarzt

Volumn 50, Issue 9, 1999, Pages 643-648

  Schoppelrey, Hans Peter ^a,b   Breit, Reinhard ^a  

^a Krankenhaus München   (Germany)

^b Klinikum Schwabing   (Germany)

Author keywords

AIDS; HIV; Immunosuppression; Phototherapy; UV radiation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PHOTOTHERAPY; PRURITUS; PSORIASIS; PUVA; SKIN DISEASE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VIRUS INFECTION;

EID: 0032861424     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050974     Document Type: Article

References (41)

1. Agathos M, Breit R (1993) Intervalltherapie der Dermatitis atopica mit UVA-1. Zentralbl Haut Geschlkr 162, Supplement, Tagungsbericht:37.Tagung DDG:91
2. Beer JZ, Olvey KM, Lee W, Zmudzka BZ (1994) Reassessment of the differential effects of ultraviolet and ionizing radiation on HIV promoter: the use of cell survival as the basis for comparison. Photochem Photobiol 59:643-649
3. Beer JZ, Zmudzka BZ (1997) UVB and PUVA therapies in HIV patients: are they safe? Photodermatol Photoimmunol Photomed 13:91-92
4. Bisaccia E, Berger C, Klainer A (1990) Extracorporal photopheresis in the treatment of AIDS-related complex: a pilot study. Ann Intern Med 113:270-275
5. Blauvelt A, Katz SI (1995) The skin as target, vector and effector organ in human immunodeficiency virus disease. J Invest Dermatol 103:122-126
6. Bör J, Schothorst AA, Suurmond D (1989) UV-B phototherapy of psoriasis. Dermatologica 161:250-258
7. Buchness MR, Lim HW, Hatcher VA (1987) Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome: treatment with ultraviolet B phototherapy. N Engl J Med 318:1183-1186
8. Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G, Briand P (1990) In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1, long terminal repeat. J Clin Invest 86:1369-1374
9. Cimarelli A, Zambruno G, Marconi A, Girolomoni G, Bertazzoni U, Giannetti A (1994) Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr 7:230-235
10. Diepgen TL, Fartasch M (1992) Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm Venereol 176:13-18
11. Dover JS, Johnson RA (1991) Cutaneous manifestations of human immunodeficiency virus infection. Part I and II. Arch Dermatol 127:1383-1391 und 1549-1558
12. Fotiades J, Lim HW, Jiang SB, Soter NA, Sanchez M, Moy J (1995) Efficacy of ultraviolet B phototherapy for psoriasis in patients infected with human immunodeficiency virus. Photodermatol Photoimmunol Photomed 11:107-111
13. Garbe C, Husak R, Orfanos CE (1994) HIV-assoziierte Dermatosen und ihre Prävalenz bei 456 HIV-Infizierten. Hautarzt 45:623-629
14. Gelfand JM, Rudikoff D, Lebwohl M, Klotman ME (1998) Effect of UV-B phototherapy on HIV type 1 RNA viral level: a self-controlled prospective study. Arch Dermatol 134:940-945
15. Gregory N (1994) Clinical manifestations of photosensitivity in patients with human immunodeficiency virus infection. Arch Dermatol 130:630-633
16. Henseler T, Wolff K, Hönigsmann H, Christophers E (1981) Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres. Lancet: 853-857
17. Herreros F, Hernandez JM, Sendino R, Del Campo I, Zazo V, Lecona M. (1996) PUVA Therapy and HIV infection. Congress of the European Academy of Dermatology and Venerology, Lissabon, 13.10-17.10.1996: Poster
18. Horn TD, Morison WI, Farzadegan H, Zmudzka BZ, Beer JZ (1994) Effects of psoralen plus UVA radiation (PUVA) on HIV-1 in human beings: a pilot study. J Am Acad Dermatol 31:735-740
19. Hudson JB, Graham EA, Harris L, Ashwood-Smith MJ (1992) The unusual UVA-dependent antiviral properties of the furoisocoumarin, coriandrin. Photochem Photobiol 57:491-496
20. James WD, Redfield RR, Lupton GP (1985) A papular eruption associated with human T cell lymphotropic virus type III disease. J Am Acad Dermatol 13:563-566
21. Kaporis A, Lim HW, Moy J, Soter NA, Sanchez M (1995) Skin response to ultraviolet B light in patients infected with human immunodeficiency virus. Photodermatol Photoimmunol Photomed 11:188-191
22. Kim T-Y, Kripke ML, Ullrich SE (1990) Immunosuppression by factors released from UV-irradiated epidermal cells. J Invest Dermatol 94:26-32
23. Meola T, Soter NA, Ostreicher R, Sanchez M, Moy JA (1993) The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol 29:216-220
24. Morrey JD, Bourn SM, Bunch TD (1992) In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 65:5045-5051
25. Obuch ML, Maurer ZA, Becker B, Berger TG (1992) Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol 27:667-673
26. Pardo RJ, Bogaert MA, Penneys NS, Byrne GE, Ruiz P (1992) UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol 26:423-428
27. Pope M, Betjes MG, Romani N, Hirmand H, Camerom PU, Hoffman L, Gezelter S, Schuler G, Steinman RM (1994) Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78:389-398
28. Ramsauer J, Plettenberg A, Meigel W (1996) HIV-assoziierte Hauterkrankungen - Teil 1. Hautarzt 47:798-813 und (1997) Teil 2. Hautarzt 48:58-72
29. Ramsauer J, Plettenberg A, Meigel W (1996) HIV-assoziierte Hauterkrankungen - Teil 1. Hautarzt 47:798-813 und (1997) Teil 2. Hautarzt 48:58-72
30. Ranki A, Puska P, Mattinen S, Lagerstedt A, Krohn K (1991) Effect of PUVA on immunologic and virologic findings in HIV-infected patients. J Am Acad Dermatol 24:404-410
31. Ring J, Fröschl M, Brunner R, Braun-Falco O (1986) LAV/HTLV-III infection and atopy: serum IgE and specific IgE antibodies to environmental allergens. Acta Derm Venereol 66:530-533
32. Röcken M, Breit R (1989) Immunologische, allergologische und pseudo-allergische Phänomene bei HIV-Positiven. In Jäger H (Hrsg) AIDS und HIV-Infektionen, ecomed, Landsberg, V-1.5
33. Rosenthal NE, Brown C, Oren DA, Galetto G, Schwartz PJ, Malley JD (1993) Effects of light on T-cells in HIV-infected subjects are not dependent on history of seasonal affective disorder. Photochem Photobiol 59:314-319
34. Schwarz T (1988) Die Bedeutung epidermaler Zytokine in der UV-induzierten Immunsuppression. Hautarzt 39:642-646
35. Schwarz T, Luger TA (1993) UV-light as epidermal cell derived cytokines. In: Luger TA, Schwarz T (eds) Epidermal growth factors and cytokines. Marcel Dekker, New York, pp 303-324
36. Simon JC et al. (1991) Ultraviolet B-radiation converts Langerhans-cell from immunogenic to tolerogenic antigen-presenting cells. J Immunoll 46:489-491
37. Stern RS, Mills DK, Krell K, Zmudzka BZ, Beer JZ. (1998) HIV-positive patients differ from HIV-negative patients in indications for and type of UV therapy used. J Am Acad Dermatol 39:48-55
38. Valerie K, Delers A, Bruch C (1988) Activation of human immunodeficiency virus Type 1 by DNA damage in human cells. Nature 333:78-81
39. Valerie K, Rosenberg M (1990) Chromatic structure implicated in activation of HIV-1 gene expression by ultraviolet light. N Biol 2:712-718
40. Vanscheidt W (1993) Psoriasis - eine immunologische Erkrankung? Hautarzt 44: Beilage
41. Zmudzka BZ, Beer JZ (1990) Activation of human immunodeficiency virus by ultraviolet radiation. Photochem Photobiol 52:1153-1162